The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder
Acknowledgement to the authors: Tarique Perera a, Mark S. George b,c, Geoffrey Grammer d, Philip G. Janicak e, Alvaro Pascual-Leone f, Theodore S. Wirecki
Date: 2016
The Clinical TMS Society Consensus (2016) Brain Stimulation
Prefrontal Transcranial Magnetic Stimulation (TMS) therapy repeated daily over 4–6 weeks (20–30 sessions) is US Food and Drug Administration (FDA) approved for treating Major Depressive Disorder in adults who have not responded to prior antidepressant medications. In 2011, leading TMS clinical providers and researchers created the Clinical TMS Society (cTMSs)
Updated: 4 August 2025
